In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes

Context: Bergenin, isolated from the herb of Bergenia purpurascens (Hook. f. et Thoms.) Engl., has anti-inflammatory, antitussive, and wound healing activities. However, whether bergenin affects the activity of human liver cytochrome P450 (CYP) enzymes remains unclear. Materials and methods: In this...

Full description

Bibliographic Details
Main Authors:	Gang Dong, Yun Zhou, Xiaoli Song
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-01-01
Series:	Pharmaceutical Biology
Subjects:	cyp3a4 cyp2e1 cyp2c9 herb–drug interaction
Online Access:	http://dx.doi.org/10.1080/13880209.2018.1525413

Similar Items

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
by: Ning Zhang, et al.
Published: (2019-01-01)

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
by: Xunge Zhang, et al.
Published: (2020-01-01)

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
by: Yang Li, et al.
Published: (2020-01-01)

In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes
by: Shangchen Xu, et al.
Published: (2020-01-01)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
by: Jinlan Wei, et al.
Published: (2018-01-01)

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA
by: T. A. Bairova, et al.
Published: (2018-09-01)

Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
by: Masako Yasuhara, et al.
Published: (2016-04-01)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01)

Modulatory effects of Benjakul extract on rat hepatic cytochrome P450 enzymes
by: Suchittra Samuhasaneeto, et al.
Published: (2021-11-01)

Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase
by: Shaheena Parween, et al.
Published: (2019-10-01)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
by: Megan E. Solan, et al.
Published: (2023-01-01)

Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
by: Tyler C. Beck, et al.
Published: (2021-05-01)

Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast
by: Sangeeta Shrestha Sharma, et al.
Published: (2023-01-01)

The responses of the growth, cytochrome P450 isoenzymes activities and the metabolomics in earthworms to sublethal doses of dichlorvos in soil
by: Xiaoxia Yang, et al.
Published: (2021-01-01)

Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs
by: Oelfah Patel, et al.
Published: (2016-11-01)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
by: Thien-Kim Le, et al.
Published: (2022-12-01)

Frequencies of Combined Dysfunction of Cytochromes P450 2C9, 2C19, and 2D6 in an Italian Cohort: Suggestions for a More Appropriate Medication Prescribing Process
by: Giovanna Gentile, et al.
Published: (2023-08-01)

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients
by: Reyhaneh Kameli, et al.
Published: (2016-11-01)

Exploring the Chemical Space of Cytochrome P450 Inhibitors using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models
by: Yusra Sajid Kiani, et al.
Published: (2019-05-01)

In vitro study of modulatory effects of Strobilanthes crispus extracts on human cDNA-expressed cytochrome P450 2A6 (CYP2A6) and CYP3A4
by: pan, Yan, et al.
Published: (2016)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ASSAY OF SUBSTRATES-MARKERS OF MAIN CYTOCHROME P450 ISOFORMS AND THEIR METABOLITES USING HPLC-MS/MS
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450
by: Fei Lin, et al.
Published: (2023-02-01)

Sensing the Generation of Intracellular Free Electrons Using the Inactive Catalytic Subunit of Cytochrome P450s as a Sink
by: Damilare D. Akintade, et al.
Published: (2020-07-01)

Cytochrome P450 enzymes inhibitor in the control of Digitaria insularis
by: Gledson Soares de Carvalho, et al.
Published: (2021-03-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism
by: Wei Wang, et al.
Published: (2016-05-01)

Evaluation of lentinan effects on cytochrome P450 activity in rats by a cocktail method
by: Yiping Lin, et al.
Published: (2019-03-01)

A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
by: Kaoru Yoshioka, et al.
Published: (2017-06-01)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
by: Gonzalo Villapalos-García, et al.
Published: (2021-10-01)

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters
by: Eszter Fliszár-Nyúl, et al.
Published: (2022-12-01)

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
by: Sam Mostafa, et al.
Published: (2021-08-01)

Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
by: Yolanda Macías, et al.
Published: (2021-09-01)

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects
by: Dorofeeva MN, et al.
Published: (2019-11-01)

Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents
by: Seetha Ramasamy, et al.
Published: (2014-02-01)

POLYMORPHISM OF CYTOCHROME P450 2A6 (CYP2A6*1 AND CYP2A6*4) AMONG JAVANESE INDONESIAN SMOKER AND NON SMOKER
by: Christine Patramurti, et al.
Published: (2015-01-01)

Effects of ginkgo leaf tablet on the pharmacokinetics of rosiglitazone in rats and its potential mechanism
by: Xueting Xing, et al.
Published: (2022-12-01)

Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard
by: Mohammad A. Alshabeeb, et al.
Published: (2022-08-01)

Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish
by: Wenjing Dong, et al.
Published: (2023-02-01)

Enzymatic activity in turkey, duck, quail and chicken liver microsomes against four human cytochrome P450 prototype substrates and aflatoxin B1
by: Hansen W. Murcia, et al.
Published: (2011-10-01)